ADRENALINE AGUETTANT 0.1 mg/ml price in UAE

Overview

Welcome to Dwaey, specifically on ADRENALINE AGUETTANT 0.1 mg/ml Injection/Solution for page.
This medicine contains an important and useful components, as it consists of Adrenaline (as acid tartrate).
ADRENALINE AGUETTANT 0.1 mg/ml is available in the market in concentration 0.1mg/ml and in the form of Injection/Solution for.

LABORATOIRE AGUETTANT is the producer of ADRENALINE AGUETTANT 0.1 mg/ml and it is imported from FRANCE, The most popular alternatives of ADRENALINE AGUETTANT 0.1 mg/ml are listed downward .

Mode Of Action

Epinephrine, an active principle of the adrenal medulla, is a direct-acting sympathomimetic. It stimulates alpha- and beta-adrenergic receptors resulting in relaxation of smooth muscle of the bronchial tree, cardiac stimulation and dilation of skeletal muscle vasculature. It is frequently added to local anaesthetics to retard diffusion and limit absorption, to prolong the duration of effect and to lessen the danger of toxicity.

Indication

Cardiac arrest
Anaphylaxis
Superficial bleeding
Acute asthma

Precaution

CV diseases; hyperthyroidism; DM; Parkinson's disease; elderly; pregnancy, lactation. Lactation: Unknown if excreted into breast milk; use caution.

Side Effects

Angina
Anxiety
Apprehensiveness
Cardiac arrhythmias
Dizziness
Dyspnea
Flushing
Headache
Hypertension
Nausea
Nervousness
Pallor
Palpitations
Respiratory difficulties
Restlessness
Sweating
Tachycardia
Tremor
Vasoconstriction
Vomiting
Weakness

Contra indication

Preexisting hypertension; occlusive vascular disease; angle-closure glaucoma (eye drops); hypersensitivity; cardiac arrhythmias or tachycardia. When used in addition to local anaesthetics: Procedures involving digits, ears, nose, penis or scrotum.

Pregnancy and lactation

Pregnancy category: C

Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks

Interaction

Halogenated inhalation anaesthetics; alpha- or beta-blocking agents; methyldopa, guanethidine; drugs with vasoconstrictor and pressor effects; antihypertensives; adrenergic neuron blockers; potassium-depleting drugs; cardiac glycosides; ephedra, yohimbe. TCAs may induce hypertension and arrhythmia.